US Agencies OK Resumption of J&J COVID Vaccine Use Despite Clot Risk
U.S. health officials on Friday ended an 11-day pause on COVID-19 vaccinations using Johnson & Johnson's one-dose shot, after scientific advisers decided its benefits outweighed the risk of rare blood clots.The government found 15 vaccine recipients who had developed the clots, out of nearly 8 million people…